Korea Investment Corp Merck & Co., Inc. Transaction History

Korea Investment Corp

$38.6 Billion
Q1 2024

A detailed history of Korea Investment Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Korea Investment Corp holds 2,256,153 shares of MRK stock, worth $279 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

2,256,153

Previous 2,537,435 11.09%

Holding current value

$279 Million

Previous $277 Million 7.62%

% of portfolio

0.77%

Previous 0.74%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $31.9 Million - $37.1 Million	-281,282 Reduced 11.09%	2,256,153 $298 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $7.65 Million - $8.33 Million	76,378 Added 3.1%	2,537,435 $277 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $11.9 Million - $13.3 Million	115,906 Added 4.94%	2,461,057 $253 Million
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $14,770 - $16,099	136 Added 0.01%	2,345,151 $271 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $34.4 Million - $38.4 Million	-334,369 Reduced 12.48%	2,345,015 $249 Million

Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $11.1 Million - $14.2 Million	-126,866 Reduced 4.52%	2,679,384 $297 Million
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $5.3 Million - $5.95 Million	62,708 Added 2.29%	2,806,250 $242 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $4.6 Million - $5.21 Million	55,077 Added 2.05%	2,743,542 $250 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $53.4 Million - $59.8 Million	725,867 Added 36.99%	2,688,465 $221 Million
Q4 2021 Feb 09, 2022	SELL	$72.28 - $90.54 $37.3 Million - $46.7 Million	-515,621 Reduced 20.81%	1,962,598 $150 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $67.2 Million - $73.9 Million	-937,353 Reduced 27.44%	2,478,219 $186 Million
Q2 2021 Aug 12, 2021	SELL	$70.31 - $77.77 $9.14 Million - $10.1 Million	-130,014 Reduced 3.67%	3,415,572 $266 Million
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $21.7 Million - $25.5 Million	-314,728 Reduced 8.15%	3,545,586 $273 Million
Q4 2020 Feb 10, 2021	BUY	$71.77 - $79.65 $17.3 Million - $19.2 Million	240,500 Added 6.64%	3,860,314 $316 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $18.4 Million - $20.9 Million	-251,500 Reduced 6.5%	3,619,814 $300 Million
Q2 2020 Aug 12, 2020	BUY	$70.42 - $80.13 $8.31 Million - $9.45 Million	117,990 Added 3.14%	3,871,314 $299 Million
Q1 2020 May 14, 2020	SELL	$63.36 - $87.82 $16 Million - $22.2 Million	-252,631 Reduced 6.31%	3,753,324 $289 Million
Q4 2019 Feb 11, 2020	BUY	$77.58 - $87.54 $38 Million - $42.8 Million	489,200 Added 13.91%	4,005,955 $364 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $18.1 Million - $19.7 Million	238,000 Added 7.26%	3,516,755 $296 Million
Q2 2019 Aug 12, 2019	BUY	$69.84 - $81.59 $76.9 Million - $89.9 Million	1,101,500 Added 50.59%	3,278,755 $275 Million
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $5.14 Million - $5.87 Million	73,942 Added 3.52%	2,177,255 $181 Million
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $3.65 Million - $4.23 Million	-55,900 Reduced 2.59%	2,103,313 $161 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $9.75 Million - $11.5 Million	-168,940 Reduced 7.26%	2,159,213 $153 Million
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $609,960 - $716,640	12,000 Added 0.52%	2,328,153 $0
Q1 2018 May 09, 2018	SELL	$50.96 - $59.23 $482,183 - $560,434	-9,462 Reduced 0.41%	2,316,153 $126 Million
Q4 2017 Feb 12, 2018	SELL	$51.62 - $61.64 $12.6 Million - $15.1 Million	-244,380 Reduced 9.51%	2,325,615 $131 Million
Q3 2017 Oct 25, 2017	BUY	$58.67 - $63.13 $151 Million - $162 Million	2,569,995	2,569,995 $165 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.

Account

Korea Investment Corp Merck & Co., Inc. Transaction History